Revitacare (Cytocare) | About the Brand

REVITACARE (Cyctocare)

ABOUT THE BRAND

Founded in 2003 and headquartered in Ile de France, France, REVITACARE is a laboratory which has its focus in the design, research, and manufacturing of hyaluronic-acid based medical devices. These products are dedicated to the cosmetology and aesthetic medicine space, aiming to correct and prevent multiple skin aging and hair treatment problems. The laboratory formulates highly-complex solutions for the medical aesthetic space, and by partnering with other entities, provide their solutions to both clinics and patients in over 45 countries all over the world.  

REVITACARE is the parent company to Cytocare Technologies Pvt Ltd, which is a service provider for multiple medical oncologists, clinical researchers, hematologists, and regulatory experts who are involved in stem cell therapy and cell processing. Cytocare Technologies is also an authorized representative for Miltenyi Biotec Clinical products in India. REVITACARE has around 30 employees in France, and has an estimated annual revenue of $16.44 million for 2020. Their products have the CE mark certification, and include the Cytocare skincare line, as well as the Haircare hair treatment line. 

 

DISCLAIMER

Information on Peak Medical Wholesale is provided for informational purposes only and may not cover all precautions, side effects, and other information about any given product. Peak Medical Wholesale cannot guarantee the accuracy of all information here, including but not limited to instructions for use. Peak Medical Wholesale reserves the right to change product prices at any time before billing customer and cannot guarantee all products listed on the website are available at any given time. All brand names and product images on Peak Medical Wholesale belong to their respective owners and Peak Medical Wholesale is in no way affiliated with the manufacturers of these products. Only qualified and suitably-trained medical practitioners should purchase and use medical products.